Myanmar Pharmaceuticals & Healthcare Q3 2018
The new Myanmar Companies Act marks one of the biggest changes in Myanmar's regulatory landscape - seeking toopen up previously closed sections of Myanmar's economy to foreign investment including for the medical equipment andpharmaceuticals sectors. The new law will likely provide a boost to increase pharmaceutical FDI and will likely see foreign inflowspick up gradually over the coming quarters. The act will also foster growth in small to medium enterprises, including in healthcare,resulting in greater foreign-domestic partnerships and joint ventures, and boosting the transfer of skills and capital into theMyanmar economy.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook